111 related articles for article (PubMed ID: 15452259)
1. Enhanced apoptosis of peripheral CD5-negative B lymphocytes from chronically hepatitis C virus-infected patients: reversal after antiviral treatment.
Toubi E; Kessel A; Peri R; Shmuel Z; Bamberger E; Sabo E; Zuckerman E
J Virol; 2004 Oct; 78(20):11379-84. PubMed ID: 15452259
[TBL] [Abstract][Full Text] [Related]
2. Peripheral B-cell CD5 expansion and CD81 overexpression and their association with disease severity and autoimmune markers in chronic hepatitis C virus infection.
Zuckerman E; Slobodin G; Kessel A; Sabo E; Yeshurun D; Halas K; Toubi E
Clin Exp Immunol; 2002 May; 128(2):353-8. PubMed ID: 11985527
[TBL] [Abstract][Full Text] [Related]
3. Differential susceptibility of peripheral blood CD5+ and CD5- B cells to apoptosis in chronic hepatitis C patients.
Mizuochi T; Ito M; Takai K; Yamaguchi K
Biochem Biophys Res Commun; 2009 Nov; 389(3):512-5. PubMed ID: 19737536
[TBL] [Abstract][Full Text] [Related]
4. Antiviral treatment down-regulates peripheral B-cell CD81 expression and CD5 expansion in chronic hepatitis C virus infection.
Zuckerman E; Kessel A; Slobodin G; Sabo E; Yeshurun D; Toubi E
J Virol; 2003 Oct; 77(19):10432-6. PubMed ID: 12970428
[TBL] [Abstract][Full Text] [Related]
5. Lack of full CD8 functional restoration after antiviral treatment for acute and chronic hepatitis C virus infection.
Missale G; Pilli M; Zerbini A; Penna A; Ravanetti L; Barili V; Orlandini A; Molinari A; Fasano M; Santantonio T; Ferrari C
Gut; 2012 Jul; 61(7):1076-84. PubMed ID: 22337949
[TBL] [Abstract][Full Text] [Related]
6. Enhanced B-cell differentiation and reduced proliferative capacity in chronic hepatitis C and chronic hepatitis B virus infections.
Oliviero B; Cerino A; Varchetta S; Paudice E; Pai S; Ludovisi S; Zaramella M; Michelone G; Pugnale P; Negro F; Barnaba V; Mondelli MU
J Hepatol; 2011 Jul; 55(1):53-60. PubMed ID: 21145853
[TBL] [Abstract][Full Text] [Related]
7. Severity of liver disease predicts the development of glucose abnormalities in patients with chronic hepatitis B or C following achievement of sustained virological response to antiviral therapy.
Chehadeh W; Al-Nakib W
J Med Virol; 2009 Apr; 81(4):610-8. PubMed ID: 19235842
[TBL] [Abstract][Full Text] [Related]
8. CD81 expression on CD19+ peripheral blood lymphocytes is associated with chronic HCV disease and increased risk for HCV infection: a putative role for inflammatory cytokines.
D'Agosto G; Trento E; Nosotti L; Bordignon V; Battista M; Prignano G; Pimpinelli F; Biolcati G; Macrì A; Palamara G; Miglioresi L; Morrone A; Di Carlo A; Cordiali-Fei P; Ensoli F
J Biol Regul Homeost Agents; 2009; 23(3):155-64. PubMed ID: 19828092
[TBL] [Abstract][Full Text] [Related]
9. The 1F7 idiotype is selectively expressed on CD5+ B cells and elevated in chronic hepatitis C virus infection.
Davtyan TK; Hovsepyan MP; Mkhitaryan LM; Hakobyan GS; Brazil A; Barrett L; Hirsch G; Peltekian KM; Grant MD
Immunol Cell Biol; 2009; 87(6):457-63. PubMed ID: 19333248
[TBL] [Abstract][Full Text] [Related]
10. Restoration of HCV-specific T cell functions by PD-1/PD-L1 blockade in HCV infection: effect of viremia levels and antiviral treatment.
Urbani S; Amadei B; Tola D; Pedrazzi G; Sacchelli L; Cavallo MC; Orlandini A; Missale G; Ferrari C
J Hepatol; 2008 Apr; 48(4):548-58. PubMed ID: 18280607
[TBL] [Abstract][Full Text] [Related]
11. Nuclear factor-kappa B in the liver of patients with chronic hepatitis C: decreased RelA expression is associated with enhanced fibrosis progression.
Boya P; Larrea E; Sola I; Majano PL; Jiménez C; Civeira MP; Prieto J
Hepatology; 2001 Nov; 34(5):1041-8. PubMed ID: 11679977
[TBL] [Abstract][Full Text] [Related]
12. Analysis of B-lymphocyte differentiation in patients infected with hepatitis C virus.
Fournillier A; Freida D; Defrance T; Merle P; Trépo C; Inchauspé G
J Med Virol; 2004 Apr; 72(4):566-74. PubMed ID: 14981759
[TBL] [Abstract][Full Text] [Related]
13. CD81 down-regulation on B cells is associated with the response to interferon-alpha-based treatment for chronic hepatitis C virus infection.
Chang LL; Cheng PN; Chen JS; Young KC
Antiviral Res; 2007 Jul; 75(1):43-51. PubMed ID: 17194487
[TBL] [Abstract][Full Text] [Related]
14. Expansion of peripheral blood CD5+ B cells is associated with mild disease in chronic hepatitis C virus infection.
Curry MP; Golden-Mason L; Nolan N; Parfrey NA; Hegarty JE; O'Farrelly C
J Hepatol; 2000 Jan; 32(1):121-5. PubMed ID: 10673076
[TBL] [Abstract][Full Text] [Related]
15. Infection of B cells with hepatitis C virus for the development of lymphoproliferative disorders in patients with chronic hepatitis C.
Inokuchi M; Ito T; Uchikoshi M; Shimozuma Y; Morikawa K; Nozawa H; Shimazaki T; Hiroishi K; Miyakawa Y; Imawari M
J Med Virol; 2009 Apr; 81(4):619-27. PubMed ID: 19235854
[TBL] [Abstract][Full Text] [Related]
16. The B lymphocyte stimulator receptor-ligand system in hepatitis C virus-induced B cell clonal disorders.
Landau DA; Rosenzwajg M; Saadoun D; Klatzmann D; Cacoub P
Ann Rheum Dis; 2009 Mar; 68(3):337-44. PubMed ID: 18434450
[TBL] [Abstract][Full Text] [Related]
17. Impaired TRAIL-dependent cytotoxicity of CD1c-positive dendritic cells in chronic hepatitis C virus infection.
Ciesek S; Liermann H; Hadem J; Greten T; Tillmann HL; Cornberg M; Aslan N; Manns MP; Wedemeyer H
J Viral Hepat; 2008 Mar; 15(3):200-11. PubMed ID: 18233993
[TBL] [Abstract][Full Text] [Related]
18. CD5-induced apoptosis of B cells in some patients with chronic lymphocytic leukemia.
Pers JO; Berthou C; Porakishvili N; Burdjanadze M; Le Calvez G; Abgrall JF; Lydyard PM; Youinou P; Jamin C
Leukemia; 2002 Jan; 16(1):44-52. PubMed ID: 11840262
[TBL] [Abstract][Full Text] [Related]
19. Evolution of hepatitis C virus-specific T cell responses and cytokine production in chronic hepatitis C patients treated with high doses of interferon-alpha.
Alvarado Esquivel C; Elewaut A; Philippé J; Elewaut AE; Desombere I; Maertens G; Leroux-Roels G
Rev Invest Clin; 2002; 54(1):41-50. PubMed ID: 11995406
[TBL] [Abstract][Full Text] [Related]
20. Production of interleukin-18 and interleukin-12 in patients suffering from chronic hepatitis C virus infection before antiviral therapy.
Schvoerer E; Navas MC; Thumann C; Fuchs A; Meyer N; Habersetzer F; Stoll-Keller F
J Med Virol; 2003 Aug; 70(4):588-93. PubMed ID: 12794721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
